Market Research Logo

Genomics Market Size, Share & Trend Analysis Report By Application, By Technology, By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2018 - 2025

Genomics Market Size, Share & Trend Analysis Report By Application, By Technology, By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2018 - 2025

The global genomics market is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the growing trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data.

Advancements in genomics and associated technologies has significantly impacted crop genetics. Technological advancements in sequencing facilitates genomes & transcriptomes sequencing for several crops. Although a reference genome exists for several crops, resequencing and gene expression studies are required for in-depth study of key genes contributing to the desired trait. Implementation of this information in crop breeding helps in development of advanced crops.

The companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company, as a result of which Bristol-Myers Squibb could deploy Foundation Medicine’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials. Such initiatives are aimed at increasing the adoption of genomic information in cancer management.

Further Key Findings From the Report Suggest:

  • High volume requirement and the high cost of specific reagents contribute to substantial revenue share. Companies are embracing the trend of offering varied reagents that simplify workflow process
  • NGS-based services held a major share in the genomics services segment due to its rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis
  • NGS-based services have witnessed a continuous growth since its introduction
  • The demand for these services would remain strong with the expansion of the customer base from being limited to academic and research centers to CROs, biotech and pharma players.
  • Biomarkers exhibit high clinical potential and efficiency across treatment of wide range of diseases
  • Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis
  • Thus biomarkers are expected to exhibit the fastest growth in the coming years over the forecast period
  • The growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive market growth in the coming years.
  • As patients are focusing on their health, Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process.
  • A few emerging and established companies are competing in this space
  • Asia Pacific is the most potential region and an emerging market for genomics. This market is anticipated to grow at the highest CAGR of 12.7%.
  • Developing infrastructure in these countries has led to the increased demand for biomarkers for diagnostics purposes.
  • Major players include BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc; Foundation Medicine, Inc, 23andMe, Inc, Danaher, Illumina, Inc; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.
  • Market participants are engaged in making the technology available to users at a lower price and in a compact form


Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
Chapter 3 Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing integration of genomics data into clinical workflows
3.1.1.1.1 More targeted and personalized healthcare
3.1.1.1.2 Growth of newborn genetic screening programs
3.1.1.1.3 Advancements in noninvasive cancer screening
3.1.1.1.4 Military genomics
3.1.1.2 Technological advances to facilitate genomic R&D
3.1.1.2.1 Emergence of advanced genome editing techniques
3.1.1.2.2 Integration of new data streams
3.1.1.2.3 RNA biology
3.1.1.2.4 Single cell biology
3.1.1.3 Rising adoption of direct to consumer genomics
3.1.1.4 Success of genetic tools in agrigenomics
3.1.1.5 Increasing participation of different companies
3.1.1.6 Increase in government role and funding in genomics
3.1.2 Market restraint analysis
3.1.2.1 Issues regarding intellectual property protection, data management, and public policies
3.1.2.2 Dearth of skilled personnel
3.2 Penetration & Growth Prospect Mapping for End use, 2016
3.3 Genomics - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Genomics Market Categorization: Product & Services Estimates & Trend Analysis
4.1 Genomics Market: Product Movement Analysis
4.2 Products
4.2.1 Global genomics products market, 2014 - 2025 (USD Million)
4.2.2 Instruments/Systems
4.2.2.1 Global genomics instruments/systems market, 2014 - 2025 (USD Million)
4.2.3 Consumables/ Reagents
4.2.3.1 Global genomics consumables/reagents market, 2014 - 2025 (USD Million)
4.3 Services
4.3.1 Global genomics services market, 2014 - 2025 (USD Million)
4.3.2 Core genomic services
4.3.2.1 Global core genomic services market, 2014 - 2025 (USD Million)
4.3.3 NGS based services
4.3.3.1 Global NGS based services market, 2014 - 2025 (USD Million)
4.3.4 Biomarker translation services
4.3.4.1 Global biomarker translation services market, 2014 - 2025 (USD Million)
4.3.5 Computational services
4.3.5.1 Global computational services market, 2014 - 2025 (USD Million)
4.3.6 Other services
4.3.6.1 Global other services market, 2014 - 2025 (USD Million)
Chapter 5 Genomics Market Categorization: Technology - Application Estimates & Trend Analysis
5.1 Global Genomics Market: Technology - Application Movement Analysis
5.2 Functional Genomics
5.2.1 Global functional genomics market, 2014 - 2025 (USD Million)
5.2.2 Transfection
5.2.2.1 Global transfection in functional genomics market, 2014 - 2025 (USD Million)
5.2.3 Real time PCR
5.2.3.1 Global real time PCR in functional genomics market, 2014 - 2025 (USD Million)
5.2.4 RNA interference
5.2.4.1 Global RNA interference in functional genomics market, 2014 - 2025 (USD Million)
5.2.5 Mutational analysis
5.2.5.1 Global mutational analysis in functional genomics market, 2014 - 2025 (USD Million)
5.2.6 SNP analysis
5.2.6.1 Global SNP analysis in functional genomics market, 2014 - 2025 (USD Million)
5.2.7 Microarray analysis
5.2.7.1 Global microarray analysis in functional genomics market, 2014 - 2025 (USD Million)
5.3 Epigenomics
5.3.1 Global epigenomics market, 2014 - 2025 (USD Million)
5.3.2 Bisulfite sequencing
5.3.2.1 Global bisulfite sequencing in epigenomics market, 2014 - 2025 (USD Million)
5.3.3 Chromatin immunoprecipitation-sequencing (ChIP-Seq)
5.3.3.1 Global chromatin immunoprecipitation-sequencing in epigenomics market, 2014 - 2025 (USD Million)
5.3.4 Methylated DNA immunoprecipitation (MeDIP)
5.3.4.1 Global methylated DNA immunoprecipitation in epigenomics market, 2014 - 2025 (USD Million)
5.3.5 High resolution melt
5.3.5.1 Global high resolution melt in epigenomics market, 2014 - 2025 (USD Million)
5.3.6 Chromatin accessibility assays
5.3.6.1 Global chromatin accessibility assays in epigenomics market, 2014 - 2025 (USD Million)
5.3.7 Microarray analysis
5.3.7.1 Global microarray analysis in epigenomics market, 2014 - 2025 (USD Million)
5.4 Pathway Analysis
5.4.1 Global pathway analysis market, 2014 - 2025 (USD Million)
5.4.2 Bead-based analysis (Bio-Plex)
5.4.2.1 Global bead-based analysis (Bio-Plex) for pathway analysis market, 2014 - 2025 (USD Million)
5.4.3 Microarray analysis
5.4.3.1 Global microarray analysis in pathway analysis market, 2014 - 2025 (USD Million)
5.4.4 Real time PCR
5.4.4.1 Global real time PCR in pathway analysis market, 2014 - 2025 (USD Million)
5.4.5 Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
5.4.5.1 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2014 - 2025 (USD Million)
5.5 Biomarker Discovery
5.5.1 Global biomarker discovery market, 2014 - 2025 (USD Million)
5.5.2 Mass spectrometry
5.5.2.1 Global mass spectrometry for biomarker discovery market, 2014 - 2025 (USD Million)
5.5.3 Real time PCR
5.5.3.1 Global real time PCR for biomarker discovery market, 2014 - 2025 (USD Million)
5.5.4 Microarray analysis
5.5.4.1 Global microarray analysis for biomarker discovery market, 2014 - 2025 (USD Million)
5.5.5 Statistical analysis
5.5.5.1 Global statistical analysis for biomarker discovery market, 2014 - 2025 (USD Million)
5.5.6 Bioinformatics
5.5.6.1 Global bioinformatics for biomarker discovery market, 2014 - 2025 (USD Million)
5.5.7 DNA sequencing
5.5.7.1 Global DNA sequencing for biomarker discovery market, 2014 - 2025 (USD Million)
5.6 Others
5.6.1 Global other services market, 2014 - 2025 (USD Million)
Chapter 6 Genomics Market Categorization: End-use Estimates & Trend Analysis
6.1 Genomics Market: End-use Movement Analysis
6.2 Clinical & Research Laboratories
6.2.1 Global clinical & research laboratories market, 2014 - 2025 (USD Million)
6.3 Academic and Government Institutes
6.3.1 Global academic and government institutes market, 2014 - 2025 (USD Million)
6.4 Hospitals and Clinics
6.4.1 Global hospital and clinics market, 2014 - 2025 (USD Million)
6.5 Pharmaceutical and Biotechnology Companies
6.5.1 Global pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
6.6 Other End Users
6.6.1 Global other end users market, 2014 - 2025 (USD Million)
Chapter 7 Genomics Market Categorization: Regional Estimates & Trend Analysis, by Product, Technology & Application, & End-use
7.1 Genomics Market Share By Region, 2015 & 2025
7.2 North America
7.2.1 North America genomics market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S genomics market, by deliverables, 2014 - 2025 (USD Million)
7.2.2.2 U.S genomics market, by application & technology, 2014 - 2025 (USD Million)
7.2.2.3 U.S genomics market, by end-use, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada genomics market, by deliverables, 2014 - 2025 (USD Million)
7.2.3.2 Canada genomics market, by application & technology, 2014 - 2025 (USD Million)
7.2.3.3 Canada genomics market, by end-use, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe genomics market, 2014 - 2025 (USD Million)
7.3.2 Germany.
7.3.2.1 Germany genomics market, by deliverables, 2014 - 2025 (USD Million)
7.3.2.2 Germany genomics market, by application & technology, 2014 - 2025 (USD Million)
7.3.2.3 Germany genomics market, by end-use, 2014 - 2025 (USD Million)
7.3.3 UK
7.3.3.1 UK genomics market, by deliverables, 2014 - 2025 (USD Million)
7.3.3.2 UK genomics market, by application & technology, 2014 - 2025 (USD Million)
7.3.3.3 UK genomics market, by end-use, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific genomics market, 2014 - 2025 (USD Million)
7.4.2 Japan.
7.4.2.1 Japan genomics market, by deliverables, 2014 - 2025 (USD Million)
7.4.2.2 Japan genomics market, by application & technology, 2014 - 2025 (USD Million)
7.4.2.3 Japan genomics market, by end-use, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China genomics market, by deliverables, 2014 - 2025 (USD Million)
7.4.3.2 China genomics market, by application & technology, 2014 - 2025 (USD Million)
7.4.3.3 China genomics market, by end-use, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America genomics market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil genomics market, by deliverables, 2014 - 2025 (USD Million)
7.5.2.2 Brazil genomics market, by application & technology, 2014 - 2025 (USD Million)
7.5.2.3 Brazil genomics market, by end-use, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA genomics market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa genomics market, by deliverables, 2014 - 2025 (USD Million)
7.6.2.2 South Africa genomics market, by application & technology, 2014 - 2025 (USD Million)
7.6.2.3 South Africa genomics market, by end-use, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Thermo Fisher Scientific, Inc.
8.3.1.1 Company overview
8.3.1.1.1 Life Technologies Corp.
8.3.1.1.2 Affymetrix, Inc.
8.3.1.1.3 Applied Biosystems
8.3.1.2 Financial performance
8.3.1.2.1 Financial performance (Affymetrix)
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Agilent Technologies
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 BGI
8.3.3.1 Company overview
8.3.3.1.1 Complete Genomics Incorporated
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Bio-Rad Laboratories, Inc.
8.3.4.1 Company overview
8.3.4.1.1 GnuBIO
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Danaher
8.3.5.1 Company overview
8.3.5.1.1 Beckman Coulter, Inc.
8.3.5.1.2 Cepheid
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 F. Hoffmann-La Roche Ltd.
8.3.6.1 Company overview
8.3.6.1.1 454 Life Sciences (Roche Diagnostics Corporation)
8.3.6.1.2 Genentech, Inc.
8.3.6.1.3 Ventana Medical Systems, Inc.
8.3.6.2 Financial performance
8.3.6.2.1 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 GE Healthcare
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Illumina, Inc.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Oxford Nanopore Technologies
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Pacific Biosciences of California, Inc.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 QIAGEN
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Quest Diagnostics Incorporated
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Foundation Medicine, Inc.
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.13.4 Strategic initiatives
8.3.14 Myriad Genetics, Inc.
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.14.4 Strategic initiatives
8.3.15 Eppendorf AG
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.16 Eurofins Scientific
8.3.16.1 Company overview
8.3.16.2 Financial performance
8.3.16.3 Product benchmarking
8.3.16.4 Strategic initiatives
8.3.17 Color Genomics, Inc.
8.3.17.1 Company overview
8.3.17.2 Financial performance
8.3.17.3 Product benchmarking
8.3.17.4 Strategic initiatives
8.3.18 23andMe, Inc.
8.3.18.1 Company overview
8.3.18.2 Financial performance
8.3.18.3 Product benchmarking
8.3.18.4 Strategic initiatives
List of Tables
TABLE 1 Gene discoveries and its application in personalized treatment for neurologic diseases
TABLE 2 North America genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 3 North America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 4 North America genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 5 North America genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 6 North America functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 7 North America epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 8 North America pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 9 North America biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 10 U.S. genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 11 U.S. genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 12 U.S. genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 13 U.S. genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 14 U.S. functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 15 U.S. epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 16 U.S. pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 17 U.S. biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 18 Canada genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 19 Canada genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 20 Canada genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 21 Canada genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 22 Canada functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 23 Canada epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 24 Canada pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 25 Canada biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 26 Europe genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 27 Europe genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 28 Europe genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 29 Europe genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 30 Europe functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 31 Europe epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 32 Europe pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 33 Europe biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 34 Germany genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 35 Germany genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 36 Germany genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 37 Germany genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 38 Germany functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 39 Germany epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 40 Germany pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 41 Germany biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 42 UK genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 43 UK genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 44 UK genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 45 UK genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 46 UK functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 47 UK epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 48 UK pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 49 UK biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 50 Asia Pacific genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 51 Asia Pacific genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 52 Asia Pacific genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 53 Asia Pacific genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 54 Asia Pacific functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 55 Asia Pacific epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 56 Asia Pacific pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 57 Asia Pacific biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 58 Japan genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 59 Japan genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 60 Japan genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 61 Japan genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 62 Japan functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 63 Japan epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 64 Japan pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 65 Japan biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 66 China genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 67 China genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 68 China genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 69 China genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 70 China functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 71 China epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 72 China pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 73 China biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 74 Latin America genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 75 Latin America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 76 Latin America genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 77 Latin America genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 78 Latin America functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 79 Latin America epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 80 Latin America pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 81 Latin America biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 82 Brazil genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 83 Brazil genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 84 Brazil genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 85 Brazil genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 86 Brazil functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 87 Brazil epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 88 Brazil pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 89 Brazil biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 90 MEA genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 91 MEA genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 92 MEA genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 93 MEA genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 94 MEA functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 95 MEA epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 96 MEA pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 97 MEA biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 98 South Africa genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 99 South Africa genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 100 South Africa genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 101 South Africa genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 102 South Africa functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 103 South Africa epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 104 South Africa pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 105 South Africa biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
List of Figures
FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Application of human genome to personal healthcare
FIG. 12 Spinal muscular atrophy (SMA) prenatal screening trend in the department of defence from 2016 to July 2017
FIG. 13 Categories of tests offered by Direct-To-Consumer (DTC) companies
FIG. 14 Global impact of biotech crop adoption in 2014
FIG. 15 Market restraint relevance analysis (Current & future impact)
FIG. 16 Penetration & growth prospect mapping for Technology, 2016
FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 18 Porter’s Five Forces Analysis
FIG. 19 Genomics market: Product outlook key takeaways
FIG. 20 Global genomics market: Product movement analysis
FIG. 21 Global genomics instruments/systems market, 2014 - 2025 (USD Million)
FIG. 22 Global genomics consumables/reagents market, 2014 - 2025 (USD Million)
FIG. 23 Global genomics services market, 2014 - 2025 (USD Million)
FIG. 24 Global core genomics services market, 2014 - 2025 (USD Million)
FIG. 25 Global NGS based services market, 2014 - 2025 (USD Million)
FIG. 26 Global biomarker translation services market, 2014 - 2025 (USD Million)
FIG. 27 Global computational services market, 2014 - 2025 (USD Million)
FIG. 28 Global other services market, 2014 - 2025 (USD Million)
FIG. 29 Genomics market: Technology - Application outlook key takeaways
FIG. 30 Global genomics market: Technology - application movement analysis
FIG. 31 Global functional genomics market, 2014 - 2025 (USD Million)
FIG. 32 Global transfection in functional genomics market, 2014 - 2025 (USD Million)
FIG. 33 Global real time PCR in functional genomics market, 2014 - 2025 (USD Million)
FIG. 34 Global RNA interference in functional genomics market, 2014 - 2025 (USD Million)
FIG. 35 Global mutational analysis in functional genomics market, 2014 - 2025 (USD Million)
FIG. 36 Global SNP analysis in functional genomics market, 2014 - 2025 (USD Million)
FIG. 37 Global microarray analysis in functional genomics market, 2014 - 2025 (USD Million)
FIG. 38 Global epigenetics market, 2014 - 2025 (USD Million)
FIG. 39 Global bisulfite sequencing in epigenetics market, 2014 - 2025 (USD Million)
FIG. 40 Global chromatin immunoprecipitation-sequencing in epigenetics market, 2014 - 2025 (USD Million)
FIG. 41 Global methylated DNA immunoprecipitation in epigenetics market, 2014 - 2025 (USD Million)
FIG. 42 Global high resolution melt in epigenetics market, 2014 - 2025 (USD Million)
FIG. 43 Global chromatin accessibility assays in epigenetics market, 2014 - 2025 (USD Million)
FIG. 44 Global microarray analysis in epigenetics market, 2014 - 2025 (USD Million)
FIG. 45 Global pathway analysis market, 2014 - 2025 (USD Million)
FIG. 46 Global luminex bead-based analysis (Bio-Plex) for pathway analysis market, 2014 - 2025 (USD Million)
FIG. 47 Global microarray analysis in pathway analysis market, 2014 - 2025 (USD Million)
FIG. 48 Global real time PCR in pathway analysis market, 2014 - 2025 (USD Million)
FIG. 49 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2014 - 2025 (USD Million)
FIG. 50 Global biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 51 Global mass spectrometry for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 52 Global real time PCR for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 53 Global microarray analysis for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 54 Global statistical analysis for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 55 Global bioinformatics for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 56 Global DNA sequencing for biomarker discovery market, 2014 - 2025 (USD Million)
FIG. 57 Global other services market, 2014 - 2025 (USD Million)
FIG. 58 Genomics market: End-use outlook key takeaways
FIG. 59 Global genomics market: End-use movement analysis
FIG. 60 Global clinical & research laboratories market, 2014 - 2025 (USD Million)
FIG. 61 Global academic and government institutes market, 2014 - 2025 (USD Million)
FIG. 62 Global hospital and clinics market, 2014 - 2025 (USD Million)
FIG. 63 Global pharmaceutical and biotechnology companies market, 2014 - 2025 (USD Million)
FIG. 64 Global other end users market, 2014 - 2025 (USD Million)
FIG. 65 Regional market place: Key takeaway
FIG. 66 Genomics regional outlook, 2016 & 2025
FIG. 67 North America genomics market, 2014 - 2025 (USD Million)
FIG. 68 U.S genomics market, 2014 - 2025 (USD Million)
FIG. 69 Canada genomics market, 2014 - 2025 (USD Million)
FIG. 70 Europe genomics market, 2014 - 2025 (USD Million)
FIG. 71 Germany genomics market, 2014 - 2025 (USD Million)
FIG. 72 UK genomics market, 2014 - 2025 (USD Million)
FIG. 73 Asia Pacific genomics market, 2014 - 2025 (USD Million)
FIG. 74 Japan genomics market, 2014 - 2025 (USD Million)
FIG. 75 China genomics market, 2014 - 2025 (USD Million)
FIG. 76 Latin America genomics market, 2014 - 2025 (USD Million)
FIG. 77 Brazil genomics market, 2014 - 2025 (USD Million)
FIG. 78 MEA genomics market, 2014 - 2025 (USD Million)
FIG. 79 South Africa genomics market, 2014 - 2025 (USD Million)
FIG. 80 Strategy framework
FIG. 81 Participant categorization

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report